Parsaclisib in Japanese patients with relapsed or refractory B-cell lymphoma (CITADEL-111): A phase Ib study.
Cancer Sci. 2022 May;113(5):1702-1711. doi: 10.1111/cas.15308. Epub 2022 Mar 15.
Cancer Sci. 2022.
PMID: 35201656
Free PMC article.
Clinical Trial.